BAFNA PHARMACEUTICALS LTD Peer Comparison
BAFNAPH · Healthcare · Current price ₹306.5
Peers tracked
11
BAFNA PHARMACEUTICALS LTD P/E
65.3x
Sector
Healthcare
BAFNA PHARMACEUTICALS LTD vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| SUN PHARMACEUTICAL IND L | ₹1,929 | 39.1x | 4,61,584 |
| DIVI S LABORATORIES LTD | ₹9,165 | 69.1x | 2,45,253 |
| TORRENT PHARMACEUTICALS L | ₹4,965.5 | 72.9x | 1,89,918 |
| ZYDUS LIFESCIENCES LTD | ₹1,167.8 | 22.0x | 1,15,282 |
| CIPLA LTD | ₹1,423 | 30.3x | 1,14,062 |
| LAURUS LABS LIMITED | ₹1,861.6 | 92.8x | 99,590 |
| LUPIN LIMITED | ₹2,153 | 20.6x | 98,010 |
| MANKIND PHARMA LIMITED | ₹2,356.5 | 53.7x | 97,908 |
| AUROBINDO PHARMA LTD | ₹1,683.3 | 25.9x | 97,199 |
| DR. REDDY S LABORATORIES | ₹1,171 | 26.8x | 97,018 |
| BAFNA PHARMACEUTICALS LTD | ₹312.6 | 47.1x | 725 |
BAFNA PHARMACEUTICALS LTD versus its peers
BAFNA PHARMACEUTICALS LTD operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 65.3x may be cheap in one industry and expensive in another.
More on BAFNA PHARMACEUTICALS LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.